Neumora Therapeutics NMRA
NASDAQ NMRA
$0.38 -0.03 (-6.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Purchase of Investments (2022 - 2025)

Updated

Analysis

Neumora Therapeutics (NMRA) Purchase of Investments (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 919.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 834.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 2.54 Bn
10 Neumora Therapeutics 69.36 Mn -548.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 38.48 Mn
Mar 31, 2025 44.39 Mn
Dec 31, 2024 106.90 Mn
Sep 30, 2024 -16,000.00
Jun 30, 2024 19.54 Mn
Mar 31, 2024 185.80 Mn
Dec 31, 2023 20.07 Mn
Sep 30, 2023 12.86 Mn
Jun 30, 2023 34.66 Mn
Mar 31, 2023 41.48 Mn
Dec 31, 2022 48.10 Mn
API Access

Neumora Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=NMRA&period=max&api_key=YOUR_API_KEY